A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

OBJECTIVE: The natural history of nonradiographic axial spondyloarthritis (SpA) is incompletely characterized, and there are concerns that nonsteroidal antiinflammatory drugs provide inadequate disease control in patients with active disease. This study was undertaken to investigate the effects of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Deodhar, Atul, Gensler, Lianne S., Kay, Jonathan, Maksymowych, Walter P., Haroon, Nigil, Landewé, Robert, Rudwaleit, Martin, Hall, Stephen, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Kilgallen, Brian, van der Heijde, Désirée
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Spondyloarthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6619287/
https://ncbi.nlm.nih.gov/pubmed/30848558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40866
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados